•  
  •  
  •  
  •  

2025-10-04 11:46:55

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Pyramid Technoplast Ltd announces commencement of its Unit IX - Recycling plant
  • AstraZeneca Pharma India Ltd receives sale and distribution approval from CDSCO for Trastuzumab Deruxtecan 100mg/5mL vial lyophilized powder
  • Uni Abex Alloy Products Ltd to sell land at Thane for Rs. 244.23 crores
  • Kesar India Ltd purchases land at Nagpur
  • Uflex Ltd commissions enhanced capacity at Sanand

Keywords Selected:  BlissGVSPharma

Stock Report

  • Bliss GVS Pharma Ltd Q1 FY2026 consolidated net profit surges to Rs. 43.03 crores
  • Bliss GVS Pharma Limited recommends final dividend of Rs. 0.50
  • Bliss GVS Pharma Ltd posts consolidated PAT of Rs. 15.53 crores in Q4FY25
  • Bliss GVS Pharma Ltd's partner gets final approval from USFDA for Mesalamine Suppositories 1000 mg
  • Bliss GVS Pharma Ltd consolidated Q1FY25 profit up at Rs. 20.69 crores
  • Bliss GVS Pharma Limited recommends final dividend of Rs. 0.50
  • Bliss GVS Pharma Limited Q4 FY2023-24 consolidated loss at Rs. 9.14 crores
  • Bliss GVS Pharma Ltd Q3 FY24 consolidated PAT slips to Rs. 27.61 crores
  • Bliss GVS Pharma Ltd posts jump in consolidated Q2 FY24 PAT to Rs. 42.30 crores
  • Bliss GVS Pharma Ltd Q1 FY2024 consolidated PAT rises QoQ to Rs. 14.68 crores
  • Bliss GVS Pharma Ltd updates on inspection by USFDA
  • BLISS GVS Pharma Ltd recommends final dividend of Rs. 0.50
  • Bliss GVS Pharma Ltd Q4 FY2023 consolidated net profit falls to Rs. 3.34 crore
  • Bliss GVS Pharma Ltd gets 3 minor observations from USFDA for Palghar unit
  • Bliss GVS Pharma Ltd Q3 FY2022-23 consolidated net profit climbs to Rs. 27.94 crores
  • Bliss GVS Pharma Ltd Q2FY23 consolidated profit lower at Rs. 13.85 crores
  • Bliss GVS Pharma Ltd posts higher consolidated PAT of Rs. 25.71 crores in Q1FY23
  • Bliss GVS Pharma Q4FY22 consolidated PAT rises to Rs. 19.63 crores
  • BLISS GVS Pharma Ltd recommends final dividend of Rs. 0.50
  • Bliss GVS Pharma Q3FY22 consolidated loss at Rs. 50.11 crore
  • Bliss GVS Pharma Ltd Q2FY22 consolidated net profit slips QoQ to Rs. 21.26 crore

Latest Post

  • Pyramid Technoplast Ltd announces commencement of its Unit IX - Recycling plant
  • AstraZeneca Pharma India Ltd receives sale and distribution approval from CDSCO for Trastuzumab Deruxtecan 100mg/5mL vial lyophilized powder
  • Uni Abex Alloy Products Ltd to sell land at Thane for Rs. 244.23 crores
  • Kesar India Ltd purchases land at Nagpur
  • Uflex Ltd commissions enhanced capacity at Sanand


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024